Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Deucravacitinib Not Associated With Clinical Remission for Patients With Moderate, Severe …,

The phase 2 LATTICE-UC study evaluating deucravacitinib for use in moderate to severe ulcerative colitis (UC) did not meet the primary efficacy endpoint of …, The phase 2 LATTICE-UC study evaluating deucravacitinib for use in moderate to severe ulcerative colitis (UC) did not meet the primary efficacy endpoint of …, Read More

Scroll to Top